Related Articles
The novel desmopressin analogue [V4Q5]dDAVP inhibits angiogenesis, tumour growth and metastases in vasopressin type 2 receptor-expressing breast cancer models
Alternative promoter activation leads to the expression of a novel human lysyl oxidase variant that functions as an amine oxidase
Modulation of growth and urokinase secretion by vasopressin and closely related nonapeptides in metastatic mouse mammary tumor cells
Effects of arginine vasopressin (AVP) on the pituitary-thyroid axis in the rat: Evidence that endogenous AVP, acting via V1 receptors, lowers TSH blood concentration
Preclinical evaluation of 99mTc direct labeling ZHER2:V2 for HER2 positive tumors imaging